LLAI Stock Discussion
LungLife AI, Inc Description
LungLife AI, Inc., a cancer diagnostics company, develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology. It engages in developing LungLB, an AI enhanced, blood-based test to utilize machine learning to identify and count CTCs with reducing operator hands-on time and increasing test performance. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. The company is based in Thousand Oaks, California.
Industry: Diagnostics & Research
Keywords: Cancer Artificial Intelligence Academic Disciplines Machine Learning Lung Cancer Medical Tests Cybernetics Computational Neuroscience
Recent Comments
- TraderMike on Trades of the Week: Jan 8 - Jan 12, 2024
- Magneto296 on Trades of the Week: Jan 8 - Jan 12, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
From the Blog
Featured Articles